NEW YORK, April 16 – Transgenomic said Monday it had appointed Gregory Duman as chief financial officer, replacing William Rasmussen, who will stay on as a strategic planner for the company.

Previously, Duman, who has been a member of Transgenomic’s board since March of last year, was the CFO of Artios, a company that provides transaction processing services. He also served as CFO and head of software product development at Transaction Systems Architects.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.